Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
about
Translating pharmacogenomics: challenges on the road to the clinicPhoto-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosisDefining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu statusBeta class II tubulin predominates in normal and tumor breast tissues.Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patientsThe HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in TherapyCopine-III interacts with ErbB2 and promotes tumor cell migrationA novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancerOverexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumorsOverexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitroCyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2Treating Metastatic Breast Cancer: The Evidence for Targeted TherapyTrastuzumab-containing regimens for metastatic breast cancerTrastuzumab containing regimens for early breast cancerLapatinib for metastatic breast cancer overexpressing HER2Trastuzumab containing regimens for early breast cancerTrastuzumab containing regimens for metastatic breast cancerEstrogen receptor alpha gene amplification in breast cancer: 25 years of debateSpontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell linesA quantitative protein interaction network for the ErbB receptors using protein microarraysAKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomasp27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent associationAn EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancerErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancersRecombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationHeregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistancePTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilizationStructural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domainsLigand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor familyBrk activates rac1 and promotes cell migration and invasion by phosphorylating paxillinPhosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell linesMEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motifCharacterisation of HER heterodimers in breast cancer using in situ proximity ligation assayIdentification of heregulin, a specific activator of p185erbB2PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancerEpidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface
P2860
Q21092371-F1D45D9D-D888-4A25-9CA7-F5AD1CA484A2Q21132316-59F11823-3FF6-4E95-99C1-827A2222B591Q21134904-7BB68527-4C6C-424E-AD35-B94DB1C20BFDQ21195160-452B35C0-5B08-464A-9E0A-00DDB2D9C452Q21195178-10ECD5E2-C526-4054-AD38-39C7A6EE5078Q21261244-B0A372C7-5487-40A4-AF90-D40A34E89592Q21284978-B7CE9BBD-9EC2-488B-B77A-3E9D3E1D42EEQ22001536-DABC61A6-8E46-41B6-92F1-5E09E2424458Q22010068-E8ECD294-E0A2-4B68-95F8-72AEC6DB3ED3Q23909424-2973DFDB-6748-479B-812E-CB17B92F1AFAQ23911300-143DDE79-9F69-49AA-A253-7EEEA3980E53Q23918146-8EF9FE1A-87CA-4081-8D98-AF3CA7EBF675Q24193683-358D9794-4F78-4936-918E-687914B2EEFCQ24194019-5B2C493E-DF9D-4317-A69A-19584983722EQ24200192-210CAF6B-F781-41C1-93F5-EDE75264077BQ24203605-C78A42BA-C8EB-42E0-AC01-0C02247CBA75Q24244420-BE26A7D7-397C-4E37-B14F-558F4A3A5B01Q24244565-DB26CCBA-9B5B-4AE2-BBD6-CEF6407128DEQ24273274-65FA2910-FA89-4487-AC13-6266CB1BBC98Q24293655-A80F5044-1B7D-4078-A8F4-71BEBFE139F0Q24293746-DA7909FC-EBE0-4DB7-9548-A02AA8D87DC1Q24294176-08BF239A-046F-4CD3-AE6F-78C9954E87B2Q24294568-47BE7171-D991-4CCF-B19E-D8813AE08B1CQ24297029-1A5E2EAA-F428-41CA-9AEB-503DFED0CE6DQ24297853-445ED2D3-12E2-4DE1-B1CA-94AD58A0D1BFQ24303562-D1495842-D829-4B49-91E5-4ADA49FA5EFEQ24306910-B4F14AC1-9AAD-41AC-B7B8-1CA2D5FB447FQ24309266-5F896A28-124C-4EEC-B809-8E512526BDEFQ24309891-F37AF46C-440F-4408-8F4A-B0D5E12390D9Q24310240-450C1608-BFCA-42AA-A9FB-8EBC82EEC724Q24310358-CDFD79F7-F85F-4D70-8BF6-9A4F49367786Q24314584-42B25E71-46E9-47FE-875B-8064B4BB905BQ24314750-7E14967E-24F6-439F-BFA9-64E4720EA952Q24318315-7AC8F0C7-7D63-479A-908E-08B425B611F0Q24318725-FF95D971-52DE-41B3-992F-BF3DAA8184A6Q24321987-E0D7560D-3257-4F87-933A-471508F350BFQ24337937-537C56DC-6293-44BA-AFEA-20FF53BAC0DBQ24338146-9C1DED13-6A06-4326-8B30-CAEAE7503C8DQ24338724-75FA8FE9-3ADC-493A-8ED3-E2B566F8ECA3Q24529941-279D648D-AA96-4ADD-9A5F-0D69EC508789
P2860
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@ast
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@en
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@nl
type
label
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@ast
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@en
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@nl
prefLabel
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@ast
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@en
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@nl
P2093
P3181
P356
P1433
P1476
Human breast cancer: correlati ...... tion of the HER-2/neu oncogene
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.3798106
P407
P577
1987-01-09T00:00:00Z